Skip to main content

Gastric carcinogenesis: when is the point of no return?

  • Chapter
Book cover Helicobacter pylori

Abstract

Over the past few years we have begun to accept a concept of carcinogenesis in which a series of mutations in important genes leads to the development of the fully fledged invasive phenotype of cancer. At the same time we have attempted, not always with success, to correlate these mutational events with the morphological pre-neoplastic lesions which have long been recognized Thus, in the colon, we subscribe to the view that most carcinomas arise from a pre-existing non-invasive lesion, the adenoma. Later research showed that the adenoma itself had a precursor lesion - the so-called aberrant crypt focus. It is now appreciated that the mutations which are associated with aberrant crypt foci and adenomas in the colon are heterogeneous, and that while we still accept the concept of sequential, mutation events leading to carcinoma, we accept that the order and timing of these events may vary, and that the mutational events themselves may be different in any given lesion. Even though knowledge of the molecular events leading to the development of carcinoma of the colon is quite extensive, it would be difficult to say, with any degree of confidence, where the point of no return in this pathway lies. There have been studies in which adenomas have been followed, without intervention, for up to 14 years before an invasive event has occurred1, and so it might be considered appropriate that the adenoma be considered the point of no return. But I shall argue that a point of no return, within the concept of carcinogenesis, is a difficult one to accept, certainly within the colon, and also, as we shall see, in the gastric mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morson B. President’s Address: the polyp-cancer sequence in the large bowel. Proc Roy Soc Med. 1974;67:451–457.

    PubMed  CAS  Google Scholar 

  2. Williams ED, Lowes AP, Willimas D, Williams GT. A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa. Am J Pathol. 1992;141:773–776.

    PubMed  CAS  Google Scholar 

  3. Park H-S, Goodlad R, Wright NA. Crypt fission in the small intestine and colon: a mechanism for the emergence of mutagen-induced transformed crypts in mice. Am J Pathol. 1995;146:1416–1427.

    Google Scholar 

  4. Bjerknes M. Expansion of mutant stem cell populations in the human colon. J Theor Biol. 1996;178:381–385.

    Article  PubMed  CAS  Google Scholar 

  5. Wright NA. Stem cell repertoire and the histogenesis of human cancer. J Roy Coll Phys (London) (in press).

    Google Scholar 

  6. Wasan H, Park H-S, Lui KC, Goodlad R, Sasieni P, Bodmer WF, Wright NA. APC in the control of crypt fission. J Pathol (in press)

    Google Scholar 

  7. Wright NA, Alison MR. The Biology of Epithelial Cell Populations. Volt pp 739. Oxford: Clarendon Press.

    Google Scholar 

  8. Fujita S, Hattori T. Cell proliferation, differentiation and migration in the gastric mucosa; a study of the background of carcinogenesis. In Farber E, Sigano H. eds. Pathophysiology of carcinogenesis in digestive organs. Baltimore: University Park Press; 1977:22–31.

    Google Scholar 

  9. Williams T, Bjerknes R. Stochastic model for abnormal clone spread through epithelial basal layers. Nature (Lond) 1972;236:19–21.

    Article  CAS  Google Scholar 

  10. Correa P. A human model for gastric carcinogenesis. Cancer Res 1988;48:3554–3560.

    PubMed  CAS  Google Scholar 

  11. Morson BC, Sobin LH, Grundmann E, Johansen A, Nogayo T, Serek-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980;33:711–721.

    Article  CAS  Google Scholar 

  12. Craanen ME, Blok P, Dekker W et al. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995;36:848–852.

    Article  PubMed  CAS  Google Scholar 

  13. Miracco C, Spina D, Vindigni C, Filipe MI, Tosi P. Cell proliferation patterns and p53 in gastric dysplasia. Int J Cancer 1995;62:149–154.

    Article  PubMed  CAS  Google Scholar 

  14. Brito MJ, Williams GT, Thompson H, Filipe MI. Expression of p53 in early (Tl) gastric carcinoma and pre-cancerous adjacent mucosa. Gut 1994;35:1697–1700.

    Article  PubMed  CAS  Google Scholar 

  15. Joypaul PV, Newman EL, Hopwood D, Grant A, Qureshi S, Lane DP, Cushieri A. Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: an immunohistochemical study. J Pathol 1993;170:279–283.

    Article  PubMed  CAS  Google Scholar 

  16. Rhyu MG, Park WS, Jung YJ, Choi SW, Meltzer SJ. Allelic deletions of MCCIAPC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 1994;106:15841588.

    Google Scholar 

  17. Sanz-Ortega J, Sanz-Esperona J, Caldes T, Gomez de la Concha E, Sobel ME, Merino MJ. LOH at the APC/MCC gene (5Q21) in gastric cancer and pre-neoplastic lesions. Pathol Res Pract 1996;192:1206–1210.

    Article  PubMed  CAS  Google Scholar 

  18. Tahara E. Molecular biology of gastric cancer. World J Surg. 1995;19:484–488.

    Article  PubMed  CAS  Google Scholar 

  19. Tahara E, Yokohazi H, Yasui W. Growth factors in gastric cancer. In Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, eds. Gastric Cancer. Tokyo: Springer Verlag; 1994:207–217.

    Google Scholar 

  20. Ochiai A, Yamanchi Y, Hirohashi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 1996;69:28–33.

    Article  PubMed  CAS  Google Scholar 

  21. Gomyo Y, Osaki M, Kaibara N, Ho H. Numerical aberration and point mutation of p53 in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis of fluorescence in situ hybridisation (FISH) and PCR-SSCP. Int J Cancer. 1996;66:594–599.

    Article  PubMed  CAS  Google Scholar 

  22. Kuipers EJ, Perez-Perez CH, Meuwissen SJ, Balser MJ. Helicobacter pylori and chronic gastritis: importance of the CagA status. J. Natl Cancer Inst. 1995;87:1777–1780.

    Article  PubMed  CAS  Google Scholar 

  23. Bukin YV, Draudin-krylenko VA, Kurshinaov YP, Poddubnij BK, Shabanov MA. Decrease of ornithine decarboxylase activity in premalignant gastric mucosa and regression of intestinal metaplasia in patients supplemented with high doses of vitamin E. Cancer Epidemiol Biomarkers Prey. 1997;6:543–546.

    CAS  Google Scholar 

  24. Farinati F, Rugge M, Di Mario F, Valiante F, Batta R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia. A prospective study. Endoscopy. 1993;25:261–264.

    Article  PubMed  CAS  Google Scholar 

  25. Digregio C, Morandi P, Fante R, Gaetani C. Gastric dysplasia: a follow-up study. Am J Gastroenterol. 1993;88:1714–1719.

    Google Scholar 

  26. Bearzi I, Brancorsini D, Santinelli A, Rezai B, Mannello P, Ranaldi R. Gastric dysplasia: a ten year follow-up study. Pathol Res Pract 1994;190:61–68.

    Article  PubMed  CAS  Google Scholar 

  27. Rugge M, Farinati F, Batta R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicentre prospective follow-up study. Gastroenterology 1994; 107:12881296.

    Google Scholar 

  28. Reed PI, Hill MJ, Johnston BC. Gastric cancer and H. pylori. Lancet 1993;342:987.

    Article  PubMed  CAS  Google Scholar 

  29. Borody TJ, Clark IW, Andrews P, Hugh TB, Shortis NP. Eradication of H. pylori may not reverse severe gastric dysplasia. Am J Gastroenterol 1995: 90;498–499.

    PubMed  CAS  Google Scholar 

  30. Recavarren-Aece S, Leon-Barua R, Cok J, et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol. 1991;26(Supp1181):51–57.

    Article  Google Scholar 

  31. Genta RM, Lew GM, Graham DY. Change in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993;6:281–289.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Wright, N.A. (1998). Gastric carcinogenesis: when is the point of no return?. In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4882-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4882-5_35

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6046-2

  • Online ISBN: 978-94-011-4882-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics